Prestige Consumer Healthcare (PBH) Treasury Shares (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Treasury Shares of $438.5 million in Q4 2025, up 11.81% quarter-over-quarter from $392.2 million in Q3 2025, and up 64.96% on a YoY basis from $265.8 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Treasury Shares (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Treasury Shares history runs 15 years deep, the most recent figure standing at $438.5 million for Q4 2025.
- In Q4 2025, Treasury Shares rose 64.96% year-over-year to $438.5 million; the TTM figure through Dec 2025 stood at $438.5 million (up 64.96% YoY), while the FY2025 annual figure was $277.2 million, up 26.22% from the prior year.
- Treasury Shares was $438.5 million for Q4 2025 at Prestige Consumer Healthcare, up from $392.2 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $8.9 million in Q4 2025 to a low of $63614.0 in Q4 2021.
- Historically, Treasury Shares has averaged $5.0 million across 5 years, with a median of $5.4 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares increased 2.23% in 2022, then soared 64.96% in 2025.
- A 5-year view of Treasury Shares shows it stood at $133.6 million in 2021, then jumped by 41.5% to $189.1 million in 2022, then grew by 16.14% to $219.6 million in 2023, then grew by 21.04% to $265.8 million in 2024, then jumped by 64.96% to $438.5 million in 2025.
- The last three Treasury Shares figures came in at $438.5 million (Q4 2025), $392.2 million (Q3 2025), and $316.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 107.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 4.80 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.42 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 17.13 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 19.58 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 7.24 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 8.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 438.55 Mn |
| Dec 31, 2025 | 8.88 Mn |
| Dec 31, 2025 | 8.88 Mn |
| Dec 31, 2025 | 438.55 Mn |
| Sep 30, 2025 | 392.23 Mn |
| Sep 30, 2025 | 8.11 Mn |
| Sep 30, 2025 | 392.23 Mn |
| Sep 30, 2025 | 8.11 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Jun 30, 2025 | 316.33 Mn |
| Jun 30, 2025 | 316.33 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Mar 31, 2025 | 277.21 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Mar 31, 2025 | 277.21 Mn |
| Dec 31, 2024 | 599,948.00 |
| Dec 31, 2024 | 265.84 Mn |
| Dec 31, 2024 | 265.84 Mn |
| Dec 31, 2024 | 599,948.00 |